메뉴 건너뛰기




Volumn 18, Issue 4, 1999, Pages 1113-1118

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARα fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)q23;q21) APL patient

Author keywords

Degradation; Leukaemia; Nuclear dot; PML; t(15; 17); Translocation

Indexed keywords

ARSENIC TRIOXIDE; HYBRID PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR;

EID: 0033611572     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202414     Document Type: Article
Times cited : (94)

References (40)
  • 11
    • 0027230533 scopus 로고
    • Degos L. (1993). Leukaemia, 7, 766-770.
    • (1993) Leukaemia , vol.7 , pp. 766-770
    • Degos, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.